STZ causes diabetes by a rapid depletion of beta-cells and, thereby, reduces insulin release and causes hyperglycemia.[11] Our study demonstrates that the EGA extract possess an antihyperglycemic activity in a dose-dependent manner on the 16th and 31st days of the treatment. This evidence concerns the gene INS and diabetes mellitus.